111
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats

, , , , , , & show all
Pages 1060-1067 | Received 13 Sep 2010, Accepted 26 Jan 2011, Published online: 21 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yoshiki Murakami, Yasumasa Shimizu, Akemi Ogasawara, Satoshi Ueshima, Mariko Nakayama, Kohei Kawata, Hiroki Kakuta & Tetsuya Aiba. (2014) Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes. Drug Development and Industrial Pharmacy 40:8, pages 1065-1071.
Read now
Qin Li, Ying Liu, Jianjie Jiao, Caili Zhang & Jianshi Lou. (2014) Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach. Drug Development and Industrial Pharmacy 40:2, pages 157-162.
Read now

Articles from other publishers (1)

Moeko Kojina, Keiichiro Suzuki, Akane Nishiwaki & Tetsuya Aiba. (2021) Acute Peripheral Inflammation Increases Plasma Concentration of Hypoglycemic Agent Nateglinide with Decreased Hepatic Drug-Metabolizing Activity in Rats. Biological and Pharmaceutical Bulletin 44:1, pages 96-102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.